Transforming growth factor-beta signaling in cancer

Citation
Jn. Rich et al., Transforming growth factor-beta signaling in cancer, MICROSC RES, 52(4), 2001, pp. 363-373
Citations number
184
Categorie Soggetti
Multidisciplinary
Journal title
MICROSCOPY RESEARCH AND TECHNIQUE
ISSN journal
1059910X → ACNP
Volume
52
Issue
4
Year of publication
2001
Pages
363 - 373
Database
ISI
SICI code
1059-910X(20010215)52:4<363:TGFSIC>2.0.ZU;2-2
Abstract
Transforming growth factor (TGF-beta) is a multifunctional polypeptide impl icated in the regulation of a variety of cellular processes including growt h, differentiation, apoptosis, adhesion, and motility. Abnormal activation or inhibition of these TGF-beta regulated processes is implicated in many d iseases, including cancer. Cancers can develop through selective exploitati on of defects in TGF-beta signaling that occur at several different levels in the pathway. The TGF-beta signal transduction cascade is initiated when TGF-beta binds to transmembrane receptors. The TGF-beta receptors then phos phorylate and activate Smad proteins, which transduce the signal from the c ytoplasm to the nucleus. In the nucleus, Smads can bind directly to DNA and cooperate with other transcription factors to induce transcription of TGF- beta target genes. Mutations in target genes, Smads, or the TGF-beta recept or are associated with certain human cancers. Microsc. Res. Tech. 52: 363-3 73, 2001. (C) 2001 Wiley-Liss, Inc.